Targeting these shared axes—whether through the modulation of autophagy, inhibition of TNF or IL-6 signaling, or fine-tuning of Wnt pathways—represents a promising translational strategy for controlling chronic inflammation and preventing bone loss in periodontal disease. The gene discussed is TNF; the disease is periodontal disorder.